Motor complications, levodopa metabolism and progression of Parkinson's disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Motor complications, levodopa metabolism and progression of Parkinson's disease
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 7, Pages 847-855
Publisher
Informa Healthcare
Online
2011-04-12
DOI
10.1517/17425255.2011.575779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients
- (2011) Thomas Müller et al. MOVEMENT DISORDERS
- Environmental Neurotoxic Pesticide Increases Histone Acetylation to Promote Apoptosis in Dopaminergic Neuronal Cells: Relevance to Epigenetic Mechanisms of Neurodegeneration
- (2010) C. Song et al. MOLECULAR PHARMACOLOGY
- Acute homocysteine rise after repeated levodopa application in patients with Parkinson’s disease
- (2010) Thomas Müller et al. PARKINSONISM & RELATED DISORDERS
- Occupation and Risk of Parkinsonism
- (2009) Caroline M. Tanner et al. ARCHIVES OF NEUROLOGY
- Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias
- (2009) C. G. Bachmann et al. EUROPEAN JOURNAL OF NEUROLOGY
- Mitochondria Are the Source of Hydrogen Peroxide for Dynamic Brain-Cell Signaling
- (2009) L. Bao et al. JOURNAL OF NEUROSCIENCE
- Homocysteine levels after acute levodopa intake in patients with Parkinson's disease
- (2009) Thomas Müller et al. MOVEMENT DISORDERS
- Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study
- (2009) Maria C. Rodriguez-Oroz et al. MOVEMENT DISORDERS
- Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy
- (2009) Davide Manca et al. MOVEMENT DISORDERS
- Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment
- (2009) Marco Onofrj et al. PARKINSONISM & RELATED DISORDERS
- Glutathione and Parkinson's disease: Is this the elephant in the room?
- (2008) Gail D. Zeevalk et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of homocysteine in the treatment of Parkinson's disease
- (2008) Thomas Müller Expert Review of Neurotherapeutics
- Molecular mechanisms underlying levodopa-induced dyskinesia
- (2008) Paolo Calabresi et al. MOVEMENT DISORDERS
- Neuropathy as a potential complication of levodopa use in Parkinson's disease
- (2008) Cory Toth et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus
- (2007) Chang-E. Zhang et al. NEUROBIOLOGY OF AGING
- Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation
- (2007) Masato Asanuma et al. NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started